| Lacosamide in status epilepticus: systematic review of current evidence A Strzelczyk, JP Zöllner, LM Willems, J Jost, E Paule, S Schubert‐Bast, ... Epilepsia 58 (6), 933-950, 2017 | 155 | 2017 |
| Repetitive magnetic stimulation induces plasticity of excitatory postsynapses on proximal dendrites of cultured mouse CA1 pyramidal neurons M Lenz, S Platschek, V Priesemann, D Becker, LM Willems, U Ziemann, ... Brain Structure and Function 220, 3323-3337, 2015 | 145 | 2015 |
| Postmarketing experience with brivaracetam in the treatment of epilepsies: a multicenter cohort study from Germany I Steinig, F von Podewils, G Möddel, S Bauer, KM Klein, E Paule, PS Reif, ... Epilepsia 58 (7), 1208-1216, 2017 | 116 | 2017 |
| Quality of life and correlating factors in children, adolescents with epilepsy, and their caregivers: A cross-sectional multicenter study from Germany J Riechmann, LM Willems, R Boor, M Kieslich, S Knake, C Langner, ... Seizure 69, 92-98, 2019 | 98 | 2019 |
| Benzodiazepines in the management of seizures and status epilepticus: a review of routes of delivery, pharmacokinetics, efficacy, and tolerability R Kienitz, L Kay, I Beuchat, S Gelhard, S von Brauchitsch, C Mann, ... CNS drugs 36 (9), 951-975, 2022 | 95 | 2022 |
| Treatment of refractory and super-refractory status epilepticus with brivaracetam: a cohort study from two German university hospitals A Strzelczyk, I Steinig, LM Willems, PS Reif, C Senft, M Voss, B Gaida, ... Epilepsy & Behavior 70, 177-181, 2017 | 95 | 2017 |
| Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticus A Strzelczyk, L Kay, S Bauer, I Immisch, KM Klein, S Knake, A Kowski, ... Epilepsia 59 (8), 1549-1556, 2018 | 76 | 2018 |
| Incidence, risk factors and consequences of epilepsy-related injuries and accidents: a retrospective, single center study LM Willems, N Watermann, S Richter, L Kay, AM Hermsen, S Knake, ... Frontiers in neurology 9, 414, 2018 | 76 | 2018 |
| Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany from 2003 to 2013—a ten-year overview LM Willems, S Richter, N Watermann, S Bauer, KM Klein, JP Reese, ... Epilepsy & Behavior 83, 28-35, 2018 | 71 | 2018 |
| Brivaracetam in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus A Strzelczyk, KM Klein, LM Willems, F Rosenow, S Bauer Expert review of clinical pharmacology 9 (5), 637-645, 2016 | 68 | 2016 |
| Noncompliance of patients with driving restrictions due to uncontrolled epilepsy LM Willems, PS Reif, S Knake, HM Hamer, C Willems, G Krämer, ... Epilepsy & Behavior 91, 86-89, 2019 | 47 | 2019 |
| Invasive EEG-electrodes in presurgical evaluation of epilepsies: Systematic analysis of implantation-, video-EEG-monitoring-and explantation-related complications, and review … LM Willems, PS Reif, A Spyrantis, A Cattani, TM Freiman, V Seifert, ... Epilepsy & Behavior 91, 30-37, 2019 | 44 | 2019 |
| Postmarketing experience with brivaracetam in the treatment of focal epilepsy in children and adolescents S Schubert-Bast, LM Willems, G Kurlemann, S Knake, K Müller-Schlüter, ... Epilepsy & Behavior 89, 89-93, 2018 | 42 | 2018 |
| Efficacy, retention, and tolerability of brivaracetam in patients with epileptic encephalopathies: a multicenter cohort study from Germany LM Willems, A Bertsche, F Bösebeck, F Hornemann, I Immisch, KM Klein, ... Frontiers in neurology 9, 569, 2018 | 41 | 2018 |
| SARS-CoV-2-related rapid reorganization of an epilepsy outpatient clinic from personal appointments to telemedicine services: a German single-center experience LM Willems, Y Balcik, AH Noda, K Siebenbrodt, S Leimeister, J McCoy, ... Epilepsy & Behavior 112, 107483, 2020 | 39 | 2020 |
| Determinants of quality of life in adults with epilepsy: a multicenter, cross-sectional study from Germany K Siebenbrodt, LM Willems, F von Podewils, PM Mross, M Strüber, ... Neurological Research and Practice 5 (1), 41, 2023 | 36 | 2023 |
| Trends in antiseizure medication prescription patterns among all adults, women, and older adults with epilepsy: A German longitudinal analysis from 2008 to 2020 M Hochbaum, R Kienitz, F Rosenow, J Schulz, L Habermehl, ... Epilepsy & Behavior 130, 108666, 2022 | 35 | 2022 |
| Recent advances in the pharmacotherapy of epilepsy: brivaracetam and perampanel as broad-spectrum antiseizure drugs for the treatment of epilepsies and status epilepticus LM Willems, S Bauer, F Rosenow, A Strzelczyk Expert Opinion on Pharmacotherapy 20 (14), 1755-1765, 2019 | 35 | 2019 |
| General trends in prices and prescription patterns of anticonvulsants in Germany between 2000 and 2017: analysis of national and cohort-based data LM Willems, HM Hamer, S Knake, F Rosenow, JP Reese, A Strzelczyk Applied health economics and health policy 17, 707-722, 2019 | 33 | 2019 |
| Intranasal midazolam as first‐line inhospital treatment for status epilepticus: a pharmaco‐EEG cohort study L Kay, N Merkel, A von Blomberg, LM Willems, S Bauer, PS Reif, ... Annals of clinical and translational neurology 6 (12), 2413-2425, 2019 | 32 | 2019 |
Felix RosenowGoethe-Universität Frankfurtmed.uni-frankfurt.de의 이메일 확인됨